Prothena Co. plc (NASDAQ:PRTA – Get Free Report)’s stock price fell 3.5% during trading on Monday . The stock traded as low as $49.18 and last traded at $49.21. 20,851 shares were traded during trading, a decline of 95% from the average session volume of 444,842 shares. The stock had previously closed at $51.00. Analyst […]
StockNews.com lowered shares of Prothena (NASDAQ:PRTA – Free Report) from a hold rating to a sell rating in a research note published on Tuesday. Several other equities analysts have also recently issued reports on the company. HC Wainwright reiterated a buy rating and set a $90.00 price target on shares of Prothena in a research […]
Jump Financial LLC purchased a new position in Prothena Co. plc (NASDAQ:PRTA – Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 32,971 shares of the biotechnology company’s stock, valued at approximately $1,598,000. Jump Financial LLC owned approximately 0.06% […]
Prothena Co. plc (NASDAQ:PRTA – Free Report) Director Dennis J. Selkoe sold 5,000 shares of Prothena stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $67.43, for a total transaction of $337,150.00. Following the sale, the director now owns 2,845 shares in the company, valued […]
Shares of Prothena Co. plc (NASDAQ:PRTA – Get Rating) dropped 4.4% during mid-day trading on Wednesday following insider selling activity. The stock traded as low as $73.02 and last traded at $73.10. Approximately 122,976 shares changed hands during trading, a decline of 74% from the average daily volume of 478,472 shares. The stock had previously […]